Better EV Stock: Rivian (RIVN) vs. Lucid (LCID)

Rivian and Lucid remain under pressure after both missed early production targets, with Rivian producing 24,337 vehicles in 2022 and Lucid 7,180 versus planned outputs of 50,000 and 20,000, respectively. Looking ahead, Rivian expects 62,000-67,000 deliveries in 2026 on the R2 launch, while Lucid forecasts 25,000-27,000 vehicles but faces a recall of more than 4,000 Gravity SUVs. The article argues Rivian is the better risk-adjusted choice given higher production rates and a potentially margin-boosting R2 SUV, though both stocks remain unprofitable and likely dilutive.

Analysis

RIVN is the cleaner expression of the “survive-to-scale” EV trade. The key second-order issue is mix shift: a lower-priced platform can expand addressable demand, but it also lowers absolute dollars of warranty, SG&A, and manufacturing inefficiency that must be absorbed before operating leverage shows up. If the new model ramps without major rework, the market will likely rerate the name well before unit economics fully inflect because EV equity tape tends to price the first credible volume glidepath 2-3 quarters ahead of reported margin improvement.

LCID’s problem is less demand than capital structure and execution convexity. A single recall on a new model is especially damaging because it delays the one product that can justify its fixed-cost base, while the Saudi backstop reduces near-term insolvency risk but also dulls discipline and prolongs dilution. In practice, that means LCID can remain “alive” longer than the market expects, but with asymmetric downside in the equity from repeated capital raises and a much lower probability of self-funded scaling over the next 12-18 months.

The contrarian setup is that both stocks may be too cheap on a sales-multiple basis, but that metric is still misleading when gross margin is negative and share count is rising. The better lens is enterprise value per incremental unit of expected 2026 revenue: RIVN’s new platform has a clearer path to turning volume into profit, while LCID’s revenue growth can still destroy value if discounting and recalls outrun manufacturing learning curves. The main risk to a bearish LCID view is a large, patient sovereign injection that bridges execution indefinitely; the main risk to a bullish RIVN view is another supply-chain or launch slip that pushes the margin inflection out by a full year.

Key Decisions for Investors

• Go long RIVN vs short LCID as a 6-12 month relative-value pair; target the spread widening if R2 ramps on schedule, with downside protected by RIVN’s higher production base and cleaner path to operating leverage.
• Buy RIVN call spreads out 9-15 months to capture the pre-launch rerating window; the trade works if the market starts discounting 2026 volumes before the actual delivery inflection.
• Avoid owning LCID outright into the next 1-2 quarters unless paired with dilution hedges; recall-related execution risk plus likely equity financing keeps risk/reward skewed negative.
• For more aggressive positioning, short-dated LCID put spreads around the next catalyst window; the setup favors downside acceleration if guidance is cut or recall costs spill into production.
• If forced to choose one long-only EV name, scale into RIVN only on pullbacks after production or supply noise, not on headline optimism; the better entry is when the market prices in delay risk but before the R2 narrative is fully reaccelerating.